TACROLIMUS IN BASE IMMUNOSUPPRESSION AFTER RENAL TRANSPLANTATION: REASONS, DOSING AND MANAGEMENT

tacrolimus, kidney transplantation, reasons for conversion, dosing

1. Mayer AD, Dimitrewski J, Squifflet J-P et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection. Transplantation 1997; 64: 436-443

2. Pirsch JD, Miller J, Deierhoi MH et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997; 63: 977-983

3. Клим Ф. Такролимус при трансплантации почки. Обзор, часть I. Нефрология 2007; 11(2): 7-25

4. Клим Ф. Такролимус при трансплантации почки. Обзор, часть II. Нефрология 2007; 11 (в печати)

5. Jordan ML, Naraghi R, Shapiro R et al. Tacrolimus for rescue of refractory renal allograft rejection. Transplant Proc 1998; 30: 1257-1260

6. Kliem V, Rademacher J, Hiss M et al. Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation. Transplant Proc 1999; 31 [Suppl 7A]: 37S-40S

7. Burrows L, Knight R, Genyk Y et al. Conversion to tacrolimus to ameliorate cyclosporine toxicity in kidney recipients. Transplant Proc 1998; 30: 2030-2032

8. Friemann S, Stopp K, Christ B et al. Conversion to tacrolimus in hyperlipidemic patients. Transplant Proc 1999; 31[Suppl 7A]: 41S-43S

9. Arns W, Merkel F, Paul A. Umstellung auf Basis-Immunsuppression mit Tacrolimus bei akuter und chronischer Abstossung sowie Ciclosporin-Toxizitaet. In: Binswanger U, Heemann U, Margreiter R, Ringe B, Herausgeber. Tacrolimus in der Nierentransplantation. Lengerich, Pabst Science Publishers, 1999; 91-99

10. Meier M, Nitschke M, Weidtmann B et al. Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial. Transplantation 2006; 81: 1035-1040